What Is Spatial Phenotyping?

Spatial phenotyping addresses this limitation by maintaining the structural context of tissues throughout analysis. The approach is often referred to as spatial profiling, a broader term used to describe the measurement of proteins, RNA molecules and other biomarkers while preserving tissue architecture and cellular location.¹

By addressing this gap, spatial phenotyping helps researchers characterize cells within their native tissue environment while preserving information about their physical location and interactions with surrounding cells.¹

At the core of spatial phenotyping are three key principles: ¹

• Spatial context, which refers to identifying not only which cells are present but also where they are located within the tissue
• Cellular interactions, including communication between immune cells, stromal cells and tumor cells within complex microenvironments
• Multiplexed marker detection, where multiple proteins, RNA targets or other biomarkers are measured simultaneously in a single tissue section

Together, these capabilities provide a multidimensional view of tissue biology, supporting deeper insights into disease mechanisms, biomarker discovery and therapeutic response.

Importance of Spatial Phenotyping

Biological processes are heavily influenced by the surrounding cellular environment, tissue organization and signaling networks between neighboring cells. By preserving spatial information, researchers can investigate cell–cell interactions, identify specialized microenvironments and examine how tissue architecture shapes normal physiology and disease progression. That is why spatial phenotyping has become increasingly central to a deeper understanding of cell behavior within intact tissues rather than in isolation.²

One of the most significant advantages of spatial phenotyping is its ability to reveal complex cellular ecosystems. In tumors, for example, immune cells, stromal cells and cancer cells interact dynamically within the tumor microenvironment. Spatial analysis can identify immune evasion patterns, regions of immune activation or localized biomarker expression that may influence prognosis and therapeutic response.³ Similar principles apply in other disease settings:

• In immunology, it helps characterize immune niches and cellular communication networks during inflammation or autoimmune disease⁴
• In neuroscience, researchers use spatial approaches to study neural circuitry, regional gene expression and neurodegenerative pathology⁵
• In infectious disease research, studies benefit from the ability to localize pathogens and host immune responses within tissues⁶

Spatial phenotyping also plays a critical role in drug discovery and translational research by helping researchers evaluate target expression, mechanisms of action and tissue responses to therapies. Because spatial information is preserved, findings can be interpreted within their biological context, improving reproducibility and generating more meaningful insights than traditional bulk analysis methods.⁷

How Spatial Phenotyping Works

Spatial phenotyping typically benefits from imaging-based workflows to analyze tissues and their structural organization. Tissue sections are stained for detecting multiple biomarkers that indicate different cell types, functional states or molecular pathways, allowing researchers to examine both cellular composition and spatial relationships within the sample.⁸

Many workflows rely on multiplex immunofluorescence or other spatially resolved assays that can detect numerous protein or RNA targets simultaneously in a single tissue section. This multiplexing capability provides a detailed view of tissue microenvironments and cellular interactions that would be difficult to capture using conventional single-marker methods.⁹

After staining, high-resolution imaging systems acquire detailed images of the tissue. Specialized software then performs image processing, cell segmentation and quantitative analysis. Segmentation identifies individual cells and defines their boundaries, while downstream analysis measures marker expression, spatial organization and interactions between neighboring cells.

Data quality and successful interpretation depend on several factors:

• Marker panel design
• Tissue preservation and sample preparation
• Staining consistency
• Signal fidelity and image quality

Careful optimization across these factors is necessary to ensure accurate biomarker detection and to minimize background noise, signal overlap and other technical artifacts.

Artificial intelligence (AI) and machine learning (ML) can be integrated into spatial phenotyping workflows to manage and interpret high-dimensional datasets. These computational approaches help identify complex spatial patterns, classify cell populations and uncover biologically meaningful relationships that may not be apparent through manual analysis alone.¹⁰

Spatial Phenotyping vs. Traditional Methods

Spatial phenotyping differs from traditional biological analysis methods by preserving tissue architecture while enabling highly multiplexed molecular analysis. This allows researchers to study not only which cells are present, but also where they are located and how they interact within the tissue microenvironment.¹

Featured Product

Spatial phenotyping can also be divided into two major categories:

Protein-based approaches (spatial proteomics) measure the spatial distribution of proteins and cell-surface markers within tissues. Common examples include multiplex immunofluorescence and imaging mass cytometry.

RNA-based approaches (spatial transcriptomics) map gene-expression patterns while preserving tissue architecture, allowing researchers to examine molecular activity across different tissue regions.

Together, these complementary approaches provide insight into cellular identity, functional state and spatial organization within complex tissue environments.

As researchers increasingly recognize the importance of tissue ecosystems in disease progression and treatment response, spatial approaches have become important tools in precision medicine. By integrating morphology, molecular profiling and spatial relationships into a single workflow, spatial phenotyping supports deeper biological insight, biomarker discovery and more informed interpretation of disease processes.¹²

Applications of Spatial Phenotyping in Research and Healthcare

The ability to provide detailed insight into tissue organization, cellular interactions and disease mechanisms makes spatial phenotyping an instrumental tool in biomedical research and clinical development.

One of the most common applications is tumor microenvironment profiling, in which spatial phenotyping is used to map interactions among cancer cells, immune cells and stromal components within tumors. These insights support a deeper understanding of tumor progression, immune evasion and therapeutic response.¹³

Beyond oncology, spatial phenotyping supports research into complex diseases such as autoimmune, neurodegenerative and infectious diseases by revealing how pathological changes develop across tissue environments. ^14,15

The technology also plays a major role in biomarker discovery and validation. Spatial analysis can identify biomarkers linked to disease progression, prognosis or treatment response and reveal their localization within the tissue. This additional layer improves confidence in translational and clinical findings.¹⁶

In drug development, spatial phenotyping helps researchers investigate mechanisms of action and tissue-level responses to experimental therapies. It is particularly valuable for studying immune infiltration and activation patterns for biologics and cell therapies, uncovering the localization and activity of immune cells within diseased tissues upon treatment.⁷

Together, these capabilities help advance precision medicine research by supporting more targeted therapeutic strategies and patient-specific treatment approaches.

Spatial Phenotyping of the Tumor Microenvironment: Biomarkers and Immunotherapy

Spatial phenotyping is particularly valuable in oncology, where the tumor microenvironment must be studied to understand how cancer cells interact with different cell types. For the development of effective immunotherapies, spatial mapping can help researchers identify the quantity and location of biomarkers, which informs how patients respond to treatments.¹⁷

Important spatial biomarkers include immune cell infiltration patterns, the distribution of immune checkpoint molecules and the co-localization of tumor and immune cells. Furthermore, spatial analysis can determine whether cytotoxic T cells can penetrate tumor regions or remain restricted to the surrounding stroma. These patterns provide valuable insights into antitumor immune activity and immune-suppressive mechanisms in solid tumors.¹⁸

Spatial profiling is also widely used to classify tumors into immunological phenotypes such as “hot,” “cold,” and immune-excluded tumors. Hot tumors typically contain abundant infiltrating immune cells and may respond better to checkpoint inhibitors, while cold tumors lack significant immune infiltration. Immune-excluded tumors contain immune cells that remain trapped outside the tumor core, limiting effective antitumor responses. Measuring T-cell proximity to tumor cells has, therefore, become an important predictor of immunotherapy response.¹⁹

Tumor Immune Phenotypes

In addition, spatial phenotyping can help identify mechanisms of resistance that reduce treatment effectiveness. Researchers can detect immune-suppressive microenvironments, stromal barriers and myeloid cell populations that prevent immune cell infiltration or suppress T-cell activity. These findings support the development of strategies designed to overcome resistance and improve therapeutic outcomes.²⁰

Challenges and Considerations in Spatial Phenotyping

Despite its advantages, spatial phenotyping presents several technical and analytical challenges that must be carefully managed to ensure reliable results. Because the approach relies on preserving tissue structure while simultaneously measuring multiple biomarkers, sample preparation and assay optimization are critical steps in the workflow.¹

Tissue quality significantly impacts data accuracy. Fixation, sectioning and preservation affect biomarker detection and signal consistency. Researchers should optimize staining and imaging to reduce noise, signal loss and variability. Standardized protocols for tissue handling, staining, imaging and data analysis are crucial for reproducibility and reliable interpretation..²¹

Antibody validation is another important consideration, particularly in multiplex immunoassays where many markers are analyzed simultaneously. Poorly validated antibodies or cross-reactivity between markers can reduce the reliability and reproducibility of data. To address this, researchers often perform extensive validation studies and use standardized controls throughout the workflow.²²

Spatial phenotyping produces large, high-dimensional datasets demanding significant computational resources for processing, storage and analysis. As studies expand, workflow automation and efficient data management will become essential. AI/ML tools will help overcome challenges like uneven staining, segmentation errors, signal overlap and complex pattern interpretation. ²³

References

1. Moffitt JR, Lundberg E, Heyn H. The emerging landscape of spatial profiling technologiesv. Nat Rev Genet 2022;23(12):741-759.
2. Gulati GS, D’Silva JP, Liu Y, Wang L, Newman AM. Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics. Nat Rev Mol Cell Biol 2025;26(1):11-31.
3. Hammerl D, Martens JW, Timmermans M, Smid M, Trapman-Jansen AM, Foekens R, et al. Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer. Nat Commun 2021;12(1):5668.
4. Allam M, Hu T, Fang Z, Pi M, Singh A, Coskun AF. Spatial immunophenotyping using multiplexed imaging of immune follicles in secondary lymphoid tissues. PNAS nexus 2024;3(8):pgae285.
5. Wang Q, Zhu H, Deng L, Xu S, Xie W, Li M, et al. Spatial transcriptomics: biotechnologies, computational tools, and neuroscience applications. Small methods 2025;9(5):2401107.
6. Tans R, Dey S, Dey NS, Calder G, O’Toole P, Kaye PM, et al. Spatially resolved immunometabolism to understand infectious disease progression. Front Microbiol 2021;12:709728.
7. Krull D, Haynes P, Kesarwani A, Tessier J, Chen BJ, Hunter K, et al. A best practices framework for spatial biology studies in drug discovery and development: enabling successful cohort studies using digital spatial profiling. J Histotechnol 2025;48(1):7-26.
8. Forndran T, Große S, Weber G, Hausdorf L, Samsel D, Berndt A, et al. Protocol for the quantitative analysis of images retrieved by multiplex immunofluorescence staining to allow cell type-specific spatial phenotyping of markers of interest in the human placenta. Placenta 2025;166:139-144.
9. Parra ER, Ferrufino-Schmidt MC, Tamegnon A, Zhang J, Solis L, Jiang M, et al. Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissue. Sci Rep 2021;11(1):8511.
10. Manogaran S, Ramadoss R, Selvam SP, Sundar S, Krishnasamy N, Krishnakumar K, et al. Artificial Intelligence–driven spatial transcriptomics in OSCC: Mapping the tumor microenvironment and personalizing therapy. J Oral Biol Craniofac Res 2025;15(6):1862-1873.
11. Ozbek B, Ertunc O, Erickson A, Vidal ID, Gomes‐Alexandre C, Guner G, et al. Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer. The Prostate 2022;82(6):706-722.
12. Zhang J, Yin J, Heng Y, Xie K, Chen A, Amit I, et al. Spatiotemporal Omics-Refining the landscape of precision medicine. Life Med 2022;1(2):84-102.
13. Backman M, Strell C, Lindberg A, Mattsson JS, Elfving H, Brunnström H, et al. Spatial immunophenotyping of the tumour microenvironment in non–small cell lung cancer. Eur J Cancer 2023;185:40-52.
14. Hardt U, Carlberg K, af Klint E, Sahlström P, Larsson L, van Vollenhoven A, et al. Integrated single cell and spatial transcriptomics reveal autoreactive differentiated B cells in joints of early rheumatoid arthritis. Sci Rep 2022;12(1):11876.
15. Iaccarino L, La Joie R, Edwards L, Strom A, Schonhaut DR, Ossenkoppele R, et al. Spatial relationships between molecular pathology and neurodegeneration in the Alzheimer’s disease continuum. Cereb Cortex 2021;31(1):1-14.
16. Smelik M, Diaz-Roncero Gonzalez D, An X, Heer R, Henningsohn L, Li X, et al. Combining spatial transcriptomics, pseudotime, and machine learning enables discovery of biomarkers for prostate cancer. Cancer Res 2025;85(13):2514-2526.
17. van Dam S, Baars MJ, Vercoulen Y. Multiplex tissue imaging: spatial revelations in the tumor microenvironment. Cancers (Basel) 2022;14(13):3170.
18. Mateiou C, Lokhande L, Diep LH, Knulst M, Carlsson E, Ek S, et al. Spatial tumor immune microenvironment phenotypes in ovarian cancer. NPJ Precis Oncol 2024;8(1):148.
19. Walsh LA, Quail DF. Decoding the tumor microenvironment with spatial technologies. Nat Immunol 2023;24(12):1982-1993.
20. Zhang A, Miao K, Sun H, Deng C-X. Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance. Int J Biol Sci 2022;18(7):3019.
21. Lee J, Yoo M, Choi J. Recent advances in spatially resolved transcriptomics: challenges and opportunities. BMB reports 2022;55(3):113.
22. Khalfaoui L, Moore RM, Villasboas JC, Whitaker KR, Novotny BC, Thompson MA, et al. Spatial phenotyping of human bronchial airways in obstructive lung disease. Respir Res 2025;26(1):232.
23. Yousef N, Wu W, Alajaji S, Mahadevan A, S. Sultan A, Molloy EK, et al. Spatial transcriptomics and artificial intelligence: a scoping review of emerging applications in head and neck pathology. Head Neck Pathol 2026;20(1):26.